Related Experiment Video
Updated: Aug 6, 2026

08:19
Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Solid nano-lipoidal intelligent premix (SNIP): designing, optimization, and characterization
Hardik Rana1, Noopur Patel2, Vaishali Thakkar2
1Anand Pharmacy College, Anand, India. hardikrana1439@gmail.com.
Summary
This study developed a novel solid nanolipoidal intelligent premix (SNIP) to enhance Bicalutamide oral bioavailability. The SNIP formulation, utilizing Epigallocatechin-3-gallate (EGCG), significantly improved drug solubility and absorption.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Nanotechnology
Background:
- Bicalutamide exhibits poor oral bioavailability due to low solubility and P-gp efflux.
- Developing effective delivery systems is crucial for improving Bicalutamide's therapeutic efficacy.
- Natural excipients offer potential for enhanced drug formulation.
Purpose of the Study:
- To improve Bicalutamide solubility and absorption using Epigallocatechin-3-gallate (EGCG).
- To design a patient- and industry-friendly solid nanolipoidal intelligent premix (SNIP).
- To explore natural excipients for advanced drug delivery.
Main Methods:
- Investigated Bicalutamide solubility in various oils, surfactants, and cosurfactants.
- Utilized EGCG to enhance Bicalutamide absorption via P-gp interaction.
- Optimized SNIP formulation using pseudo-ternary phase diagrams and D-optimal mixture design.
- Characterized SNIP for morphology, globule size, stability, and dissolution.
Main Results:
- Identified optimal SNIP formulation with sunflower oil, Tween 20, and Span 80.
- Achieved immediate emulsification, nano-sized uniform globules (254.4 nm), and high stability.
- Demonstrated enhanced Bicalutamide solubility and amorphous nature in SNIP.
- Confirmed EGCG's efficacy in improving ex vivo drug absorption (96.75%).
Conclusions:
- Developed a novel, stable, and effective SNIP formulation for Bicalutamide.
- SNIP enhances Bicalutamide solubility and dissolution, potentially bypassing first-pass metabolism.
- EGCG significantly improves Bicalutamide absorption, offering a patient-convenient delivery system.

